Pharmacogenomic Testing

Pharmacogenomic Testing is a molecular diagnostic procedure that analyzes an individual’s germline and, where relevant, somatic genetic variants in pharmacogenes to predict drug response, including efficacy and toxicity, and thereby guide the personalized selection and dosing of pharmacotherapies.

1.8K

Publications

89.1K

Citations

9.5K

Authors

2.6K

Institutions

Publications per year

2017–2026

578

Authors

9.5K

  1. TE
    Teri E. Klein

    Stanford University, United States

    22 publications · 5.1K citations

    21

    h-index

  2. SB
    Susanne B. Haga

    Duke University, United States

    28 publications · 1.2K citations

    20

    h-index

  3. JA
    Julie A. Johnson

    University of Florida, United States

    25 publications · 2.7K citations

    20

    h-index

  4. GP
    George P. Patrinos

    University of Patras, Greece

    26 publications · 1.1K citations

    20

    h-index

  5. WB
    Wylie Burke

    University of Washington, United States

    20 publications · 1.5K citations

    17

    h-index

1–5 of 9.5K

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 88 publications · 10.2K citations

    49

    h-index

  2. Genetics in Medicine

    GIM · 72 publications · 5.6K citations

    42

    h-index

  3. Pharmacogenomics

    116 publications · 3.4K citations

    33

    h-index

  4. PubMed

    Repository · 86 publications · 2.8K citations

    32

    h-index

  5. The Pharmacogenomics Journal

    56 publications · 2.8K citations

    27

    h-index

1–5